These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22865506)

  • 1. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies.
    Shaffer LG; Dabell MP; Fisher AJ; Coppinger J; Bandholz AM; Ellison JW; Ravnan JB; Torchia BS; Ballif BC; Rosenfeld JA
    Prenat Diagn; 2012 Oct; 32(10):976-85. PubMed ID: 22865506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatally diagnosed de novo segmental amplification or deletion by microarray-based comparative genomic hybridization: A retrospective study.
    Peng HH; Lee CH; Su SY; Chen KJ; Lee YC; You SH; Lee WF; Cheng PJ
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):662-666. PubMed ID: 31542089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound.
    Shaffer LG; Rosenfeld JA; Dabell MP; Coppinger J; Bandholz AM; Ellison JW; Ravnan JB; Torchia BS; Ballif BC; Fisher AJ
    Prenat Diagn; 2012 Oct; 32(10):986-95. PubMed ID: 22847778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray.
    Coppinger J; Alliman S; Lamb AN; Torchia BS; Bejjani BA; Shaffer LG
    Prenat Diagn; 2009 Dec; 29(12):1156-66. PubMed ID: 19795450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.
    Mademont-Soler I; Morales C; Soler A; Martínez-Crespo JM; Shen Y; Margarit E; Clusellas N; Obón M; Wu BL; Sánchez A
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):375-82. PubMed ID: 23233332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of submicroscopic chromosomal aberrations by array-based comparative genomic hybridization in fetuses with congenital heart disease.
    Yan Y; Wu Q; Zhang L; Wang X; Dan S; Deng D; Sun L; Yao L; Ma Y; Wang L
    Ultrasound Obstet Gynecol; 2014 Apr; 43(4):404-12. PubMed ID: 24323407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of microarray testing in pregnancy loss.
    Rosenfeld JA; Tucker ME; Escobar LF; Neill NJ; Torchia BS; McDaniel LD; Schultz RA; Chong K; Chitayat D
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):478-86. PubMed ID: 25846569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis and molecular cytogenetic characterization of three chromosomal abnormalities with favorable outcomes.
    Chen Q; Xu Z; Chen G; Liu S; Xia Y
    Taiwan J Obstet Gynecol; 2020 Mar; 59(2):338-341. PubMed ID: 32127162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong.
    Kan AS; Lau ET; Tang WF; Chan SS; Ding SC; Chan KY; Lee CP; Hui PW; Chung BH; Leung KY; Ma T; Leung WC; Tang MH
    PLoS One; 2014; 9(2):e87988. PubMed ID: 24505343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal microarray comparative genomic hybridization: Experience from the two first years of activity at the Lyon university-hospital.
    Pons L; Till M; Alix E; Abel C; Boggio D; Bordes A; Caloone J; Raskin FC; Chatron N; Cordier MP; Fichez A; Labalme A; Lajeunesse C; Liaras É; Massoud M; Miribel J; Ollagnon E; Schluth-Bolard C; Vichier-Cerf A; Edery P; Attia J; Huissoud C; Rudigoz RC; Massardier J; Gaucherand P; Sanlaville D
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):275-283. PubMed ID: 28403926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a Chromosomal Microarray for Prenatal Diagnosis Using a Prospective Cohort of Pregnancies with Increased Risk for Chromosome Abnormalities.
    Wright D; Carey L; Battersby S; Nguyen T; Clarke M; Nash B; Gulesserian E; Cross J; Darmanian A
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):791-798. PubMed ID: 27690282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of chromosome microarray analysis in prenatal diagnosis.
    Xia M; Yang X; Fu J; Teng Z; Lv Y; Yu L
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):696. PubMed ID: 33198662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis by chromosomal microarray analysis.
    Levy B; Wapner R
    Fertil Steril; 2018 Feb; 109(2):201-212. PubMed ID: 29447663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of array comparative genomic hybridisation in prenatal setting.
    Lovrecic L; Remec ZI; Volk M; Rudolf G; Writzl K; Peterlin B
    BMC Med Genet; 2016 Nov; 17(1):81. PubMed ID: 27846804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors.
    Brady PD; Delle Chiaie B; Christenhusz G; Dierickx K; Van Den Bogaert K; Menten B; Janssens S; Defoort P; Roets E; Sleurs E; Keymolen K; De Catte L; Deprest J; de Ravel T; Van Esch H; Fryns JP; Devriendt K; Vermeesch JR
    Genet Med; 2014 Jun; 16(6):469-76. PubMed ID: 24177055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGH Array and Karyotype as Complementary Tools in Prenatal Diagnosis: Prenatal Diagnosis of a 4q Derivative Chromosome from Maternal 4q;11q Translocation.
    Gonzalez C; Serrano MG; Barbancho Lopez C; Garcia-Riaño T; Barea Calero V; Moreno Perea R; Rodriguez Mogollón B; Queipo Rojas A; Climent AG; Cava Valenciano F
    Fetal Pediatr Pathol; 2018 Jun; 37(3):184-190. PubMed ID: 29771170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal microarray versus karyotyping for prenatal diagnosis.
    Wapner RJ; Martin CL; Levy B; Ballif BC; Eng CM; Zachary JM; Savage M; Platt LD; Saltzman D; Grobman WA; Klugman S; Scholl T; Simpson JL; McCall K; Aggarwal VS; Bunke B; Nahum O; Patel A; Lamb AN; Thom EA; Beaudet AL; Ledbetter DH; Shaffer LG; Jackson L
    N Engl J Med; 2012 Dec; 367(23):2175-84. PubMed ID: 23215555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of chromosomal microarray analysis in detection of fetal chromosomal rearrangements: a study from China Mainland.
    Wu Y; Wang Y; Tao J; Han X; Zhao X; Liu C; Gao L; Cheng W
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():44-50. PubMed ID: 28340467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing.
    Cohen K; Tzika A; Wood H; Berri S; Roberts P; Mason G; Sheridan E
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):394-401. PubMed ID: 25510919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.